Modeling Ischemic Stroke in Vitro: Status Quo and Future Perspectives

Stroke

Volumn 47, Issue 2, 2016, Pages 561-569

  Holloway, Paul M ^a   Gavins, Felicity N E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood brain barrier; Endothelial cells; In vitro techniques; Stroke; Tissue type plasminogen activator

Indexed keywords

GLUCOSE; OXYGEN;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN SLICE; CELL CULTURE; DIABETES MELLITUS; DISEASE MODEL; ENZYME CHEMISTRY; EXCITOTOXICITY; EXTRACELLULAR MATRIX; HUMAN; HYPOXIC CELL; IMMORTALIZED CELL LINE; IN VITRO STUDY; IN VIVO STUDY; MICROFLUIDICS; MICROGLIA; NERVE CELL; NONHUMAN; PERICYTE; PRIMARY CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CELL LINE; CEREBROVASCULAR ACCIDENT; MEDICAL RESEARCH; ORGAN CULTURE TECHNIQUE; TUMOR CELL LINE;

ANIMALS; BIOMEDICAL RESEARCH; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; IN VITRO TECHNIQUES; MODELS, NEUROLOGICAL; ORGAN CULTURE TECHNIQUES; STEM CELLS; STROKE;

EID: 84969369431     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011932     Document Type: Review

References (57)

1. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6 suppl):S85-S90. doi: 10.1016/j.wneu.2011.07.023.
2. Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci. 2012;13:11753-11772. doi: 10.3390/ijms130911753.
3. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731-2738.
4. Syvänen S, Lindhe O, Palner M, Kornum BR, Rahman O, Långström B, et al. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos. 2009;37:635-643. doi: 10.1124/dmd.108.024745.
5. Dávalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke. 1997;28:708-710.
6. Hanke T. Lessons from TGN1412. Lancet. 2006;368:1569-1570, author reply 1570. doi: 10.1016/S0140-6736(06)69651-7.
7. Römer PS, Berr S, Avota E, Na SY, Battaglia M, ten Berge I, et al. Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood. 2011;118:6772-6782. doi: 10.1182/blood-2010-12-319780.
8. Antonic A, Sena ES, Donnan GA, Howells DW. Human in vitro models of ischaemic stroke: a test bed for translation. Transl Stroke Res. 2012;3:306-309. doi: 10.1007/s12975-012-0201-x.
9. Kurian GA, Pemaih B. Standardization of in vitro Cell-based Model for Renal Ischemia and Reperfusion Injury. Indian J Pharm Sci. 2014;76:348-353.
10. Brown RC, Davis TP. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun. 2005;327:1114-1123. doi: 10.1016/j.bbrc.2004.12.123.
11. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 1993;13:3510-3524.
12. Matsumoto K, Yamada K, Kohmura E, Kinoshita A, Hayakawa T. Role of pyruvate in ischaemia-like conditions on cultured neurons. Neurol Res. 1994;16:460-464.
13. Newell DW, Barth A, Papermaster V, Malouf AT. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J Neurosci. 1995;15:7702-7711.
14. Kalda A, Eriste E, Vassiljev V, Zharkovsky A. Medium transitory oxygen-glucose deprivation induced both apoptosis and necrosis in cerebellar granule cells. Neurosci Lett. 1998;240:21-24.
15. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience. 1995;68:615-619.
16. von Engelhardt J, Coserea I, Pawlak V, Fuchs EC, Köhr G, Seeburg PH, et al. Excitotoxicity in vitro by NR2A-and NR2B-containing NMDA receptors. Neuropharmacology. 2007;53:10-17. doi: 10.1016/j. neuropharm.2007.04.015.
17. Dong WQ, Schurr A, Reid KH, Shields CB, West CA. The rat hippocampal slice preparation as an in vitro model of ischemia. Stroke. 1988;19:498-502.
18. Richard MJ, Saleh TM, El Bahh B, Zidichouski JA. A novel method for inducing focal ischemia in vitro. J Neurosci Methods. 2010;190:20-27. doi: 10.1016/j.jneumeth.2010.04.017.
19. Werth JL, Park TS, Silbergeld DL, Rothman SM. Excitotoxic swelling occurs in oxygen and glucose deprived human cortical slices. Brain Res. 1998;782:248-254.
20. Vornov JJ, Tasker RC, Coyle JT. Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke. 1994;25:457-464.
21. Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS. 2013;10:33. doi: 10.1186/2045-8118-10-33.
22. Abney ER, Bartlett PP, Raff MC. Astrocytes, ependymal cells, and oligodendrocytes develop on schedule in dissociated cell cultures of embryonic rat brain. Dev Biol. 1981;83:301-310.
23. Gumbleton M, Audus KL. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci. 2001;90:1681-1698.
24. Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, et al. Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. J Neurosci Res. 2014;92:1187-1198. doi: 10.1002/jnr.23399.
25. He Y, Yao Y, Tsirka SE, Cao Y. Cell-culture models of the blood-brain barrier. Stroke. 2014;45:2514-2526. doi: 10.1161/STROKEAHA.114.005427.
26. Selvaraj V, Jiang P, Chechneva O, Lo UG, Deng W. Differentiating human stem cells into neurons and glial cells for neural repair. Front Biosci (Landmark Ed). 2012;17:65-89.
27. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
28. Durnaoglu S, Genc S, Genc K. Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int. 2011;2011:212487. doi: 10.4061/2011/212487.
29. Imaizumi Y, Okano H. Modeling human neurological disorders with induced pluripotent stem cells. J Neurochem. 2014;129:388-399. doi: 10.1111/jnc.12625.
30. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218-1221. doi: 10.1126/science.1158799.
31. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssière C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515. doi: 10.1016/S0140-6736(97)08083-5.
32. Cucullo L, Marchi N, Hossain M, Janigro D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab. 2011;31:767-777. doi: 10.1038/jcbfm.2010.162.
33. Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO. Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab. 2011;31:693-705. doi: 10.1038/jcbfm.2010.148.
34. Zhang W, Smith C, Howlett C, Stanimirovic D. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. J Cereb Blood Flow Metab. 2000;20:967-978. doi: 10.1097/00004647-200006000-00009.
35. Hudson LC, Bragg DC, Tompkins MB, Meeker RB. Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res. 2005;1058:148-160. doi: 10.1016/j. brainres.2005.07.071.
36. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562-566. doi: 10.1038/nature09513.
37. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28:2221-2230. doi: 10.1523/JNEUROSCI.5643-07.2008.
38. Tilling T, Korte D, Hoheisel D, Galla HJ. Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J Neurochem. 1998;71:1151-1157.
39. Inglis VI, Jones MP, Tse AD, Easton AS. Neutrophils both reduce and increase permeability in a cell culture model of the blood-brain barrier. Brain Res. 2004;998:218-229.
40. Tiede LM, Cook EA, Morsey B, Fox HS. Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins. Cell Death Dis. 2011;2:e246. doi: 10.1038/cddis.2011.128.
41. Studer L, Csete M, Lee SH, Kabbani N, Walikonis J, Wold B, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000;20:7377-7383.
42. Kleman AM, Yuan JY, Aja S, Ronnett GV, Landree LE. Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. J Neurosci Methods. 2008;167:292-301. doi: 10.1016/j. jneumeth.2007.08.028.
43. Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab. 2002;22:271-279. doi: 10.1097/00004647-200203000-00004.
44. Asthana A, Kisaalita WS. Biophysical microenvironment and 3D culture physiological relevance. Drug Discov Today. 2013;18:533-540. doi: 10.1016/j.drudis.2012.12.005.
45. Peretz H, Talpalar AE, Vago R, Baranes D. Superior survival and durability of neurons and astrocytes on 3-dimensional aragonite biomatrices. Tissue Eng. 2007;13:461-472. doi: 10.1089/ten.2005.0522.
46. East E, Golding JP, Phillips JB. A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis. J Tissue Eng Regen Med. 2009;3:634-646. doi: 10.1002/term.209.
47. Amemori T, Romanyuk N, Jendelova P, Herynek V, Turnovcova K, Prochazka P, et al. Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Ther. 2013;4:68. doi: 10.1186/scrt219.
48. Reed DM, Paschalaki KE, Starke RD, Mohamed NA, Sharp G, Fox B, et al. An autologous endothelial cell:peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics. FASEB J. 2015;29:2595-2602. doi: 10.1096/fj.14-268144.
49. Desai SY, Marroni M, Cucullo L, Krizanac-Bengez L, Mayberg MR, Hossain MT, et al. Mechanisms of endothelial survival under shear stress. Endothelium. 2002;9:89-102.
50. Krizanac-Bengez L, Mayberg MR, Cunningham E, Hossain M, Ponnampalam S, Parkinson FE, et al. Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model. J Cell Physiol. 2006;206:68-77. doi: 10.1002/jcp.20429.
51. Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier (?BBB). Lab Chip. 2012;12:1784-1792. doi: 10.1039/c2lc40094d.
52. Prabhakarpandian B, Shen MC, Nichols JB, Mills IR, Sidoryk-Wegrzynowicz M, Aschner M, et al. SyM-BBB: a microfluidic Blood Brain Barrier model. Lab Chip. 2013;13:1093-1101. doi: 10.1039/c2lc41208j.
53. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods. 2005;2:599-605. doi: 10.1038/nmeth777.
54. Ionescu-Zanetti C, Shaw RM, Seo J, Jan YN, Jan LY, Lee LP. Mammalian electrophysiology on a microfluidic platform. Proc Natl Acad Sci USA. 2005;102:9112-9117. doi: 10.1073/pnas.0503418102.
55. Nevill JT, Mo A, Cord BJ, Palmer TD, Poo M-m, Lee LP, et al. Vacuum soft lithography to direct neuronal polarization. Soft Matter. 2011;7:343-347
56. Peterman MC, Mehenti NZ, Bilbao KV, Lee CJ, Leng T, Noolandi J, et al. The artificial synapse chip: a flexible retinal interface based on directed retinal cell growth and neurotransmitter stimulation. Artif Organs. 2003;27:975-985.
57. Tsai M, Kita A, Leach J, Rounsevell R, Huang JN, Moake J, et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest. 2012;122:408-418. doi: 10.1172/JCI58753.